TY - JOUR
T1 - Protein phosphatase 2C is responsible for VP-induced ephosphorylation of AQP2 serine 261
AU - Cheung, Pui W.
AU - Ueberdiek, Lars
AU - Day, Jack
AU - Bouley, Richard
AU - Brown, Dennis
N1 - Funding Information:
This work was supported by National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) Grant DK-096586 (D. Brown). L. Ueberdiek was supported by a Kolff Student Fellowship Abroad Grant from the Dutch Kidney Foundation. P. W. Cheung was supported by NIDDKNational Institute of Diabetes and Digestive and Kidney Diseases Grant T32 5T32 DK-007540-29. J. Day was supported by an undergraduate summer research award from the American Physiological Society. R. Bouley was supported by a Massachusetts General Hospital Executive Committee on Research (MGH/ ECOR) interim support fund. The Nikon A1R confocal microscope in the Program in Membrane Biology Microscopy Core was purchased using NIHNational Institutes of Health Shared Instrumentation Grant S10 RR-031563-01 (D. Brown). Additional support for the Program in Membrane Biology Microscopy Core was provided by the Boston Area Diabetes and Endocrinology Research Center (National Institute of Diabetes and Digestive and Kidney DiseasesNIDDK Grant DK-057521) and the Massachusetts General Hospital Center for the Study of Inflammatory Bowel Disease (National Institute of Diabetes and Digestive and Kidney DiseasesNIDDK Grant DK-043351).
Publisher Copyright:
© 2017 the American Physiological Society.
PY - 2017/8/2
Y1 - 2017/8/2
N2 - Aquaporin 2 (AQP2) trafficking is regulated by phosphorylation and dephosphorylation of serine residues in the AQP2 COOH terminus. Vasopressin (VP) binding to its receptor (V2R) leads to a cascade of events that result in phosphorylation of serine 256 (S256), S264, and S269, but dephosphorylation of S261. To identify which phosphatase is responsible for VP-induced S261 dephosphorylation, we pretreated cells with different phosphatase inhibitors before VP stimulation. Sanguinarine, a specific protein phosphatase (PP) 2C inhibitor, but not inhibitors of PP1, PP2A (okadaic acid), or PP2B (cyclosporine), abolished VP-induced S261 dephosphorylation. However, sanguinarine and VP significantly increased phosphorylation of ERK, a kinase that can phosphorylate S261; inhibition of ERK by PD98059 partially decreased baseline S261 phosphorylation. These data support a role of ERK in S261 phosphorylation but suggest that, upon VP treatment, increased phosphatase activity overcomes the increase in ERK activity, resulting in overall dephosphorylation of S261. We also found that sanguinarine abolished VP-induced S261 dephosphorylation in cells expressing mutated AQP2 S256A, suggesting that the phosphorylation state of S261 is independent of S256. Sanguinarine alone did not induce AQP2 membrane trafficking, nor did it inhibit VP-induced AQP2 membrane accumulation in cells and kidney tissues, suggesting that S261 does not play an observable role in acute AQP2 membrane accumulation. In conclusion, PP2C activity is required for S261 AQP2 dephosphorylation upon VP stimulation, which occurs independently of S256 phosphorylation. Understanding the pathways involved in modulating PP2C will help elucidate the role of S261 in cellular events involving AQP2.
AB - Aquaporin 2 (AQP2) trafficking is regulated by phosphorylation and dephosphorylation of serine residues in the AQP2 COOH terminus. Vasopressin (VP) binding to its receptor (V2R) leads to a cascade of events that result in phosphorylation of serine 256 (S256), S264, and S269, but dephosphorylation of S261. To identify which phosphatase is responsible for VP-induced S261 dephosphorylation, we pretreated cells with different phosphatase inhibitors before VP stimulation. Sanguinarine, a specific protein phosphatase (PP) 2C inhibitor, but not inhibitors of PP1, PP2A (okadaic acid), or PP2B (cyclosporine), abolished VP-induced S261 dephosphorylation. However, sanguinarine and VP significantly increased phosphorylation of ERK, a kinase that can phosphorylate S261; inhibition of ERK by PD98059 partially decreased baseline S261 phosphorylation. These data support a role of ERK in S261 phosphorylation but suggest that, upon VP treatment, increased phosphatase activity overcomes the increase in ERK activity, resulting in overall dephosphorylation of S261. We also found that sanguinarine abolished VP-induced S261 dephosphorylation in cells expressing mutated AQP2 S256A, suggesting that the phosphorylation state of S261 is independent of S256. Sanguinarine alone did not induce AQP2 membrane trafficking, nor did it inhibit VP-induced AQP2 membrane accumulation in cells and kidney tissues, suggesting that S261 does not play an observable role in acute AQP2 membrane accumulation. In conclusion, PP2C activity is required for S261 AQP2 dephosphorylation upon VP stimulation, which occurs independently of S256 phosphorylation. Understanding the pathways involved in modulating PP2C will help elucidate the role of S261 in cellular events involving AQP2.
KW - Aquaporin
KW - ERK
KW - PP2C
KW - Phosphatase
KW - Vasopressin receptor
UR - http://www.scopus.com/inward/record.url?scp=85026843810&partnerID=8YFLogxK
U2 - 10.1152/ajprenal.00004.2017
DO - 10.1152/ajprenal.00004.2017
M3 - Article
C2 - 28381458
AN - SCOPUS:85026843810
SN - 0363-6127
VL - 313
SP - F404-F413
JO - American Journal of Physiology - Renal Physiology
JF - American Journal of Physiology - Renal Physiology
IS - 2
ER -